Trial NCT03624036

View at ClinicalTrials.gov 
Org. Study IDs: KTE-C19-108
Secondary IDs: 2018-001923-38

Last trial update was posted on 2023-11-18

MeSH Interventions

Brexucabtagene autoleucel Cyclophosphamide Fludarabine

MeSH Conditions

Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid Lymphoma

Other Conditions

Relapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic Lymphoma

Stopping Reasons

Development program terminated

Limitations And Caveats

N/A

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID